Charles Darwin University

CDU eSpace
Institutional Repository

 
CDU Staff and Student only
 

The case for reactive mass oral cholera vaccinations

Reyburn, Rita, Deen, Jacqueline L., Grais, Rebecca F., Bhattacharya, Sujit K., Sur, Dipika, Lopez, Anna L., Jiddawi, Mohamed S., Clemens, John D. and von Seidlein, Lorenz (2011). The case for reactive mass oral cholera vaccinations. PLoS Neglected Tropical Diseases,5(1):e952.

Document type: Journal Article
Citation counts: Altmetric Score Altmetric Score is 20
Google Scholar Search Google Scholar
Attached Files (Some files may be inaccessible until you login with your CDU eSpace credentials)
Name Description MIMEType Size Downloads
Download this reading vonSeidlein_30185.pdf Published version application/pdf 1.66MB 38
Reading the attached file works best in Firefox, Chrome and IE 9 or later.

IRMA ID kmckayxPUB36
Title The case for reactive mass oral cholera vaccinations
Author Reyburn, Rita
Deen, Jacqueline L.
Grais, Rebecca F.
Bhattacharya, Sujit K.
Sur, Dipika
Lopez, Anna L.
Jiddawi, Mohamed S.
Clemens, John D.
von Seidlein, Lorenz
Journal Name PLoS Neglected Tropical Diseases
Publication Date 2011
Volume Number 5
Issue Number 1
ISSN 1935-2727   (check CDU catalogue open catalogue search in new window)
Start Page e952
Total Pages 10
Place of Publication United States
Publisher Public Library of Science
HERDC Category C1 - Journal Article (DEST)
Abstract Introduction: The outbreak of cholera in Zimbabwe intensified interest in the control and prevention of cholera. While there is agreement that safe water, sanitation, and personal hygiene are ideal for the long term control of cholera, there is controversy about the role of newer approaches such as oral cholera vaccines (OCVs). In October 2009 the Strategic Advisory Group of Experts advised the World Health Organization to consider reactive vaccination campaigns in response to large cholera outbreaks. To evaluate the potential benefit of this pivotal change in WHO policy, we used existing data from cholera outbreaks to simulate the number of cholera cases preventable by reactive mass vaccination.

Methods:
Datasets of cholera outbreaks from three sites with varying cholera endemicity—Zimbabwe, Kolkata (India), and Zanzibar (Tanzania)—were analysed to estimate the number of cholera cases preventable under differing response times, vaccine coverage, and vaccine doses.

Findings:
The large cholera outbreak in Zimbabwe started in mid August 2008 and by July 2009, 98,591 cholera cases had been reported with 4,288 deaths attributed to cholera. If a rapid response had taken place and half of the population had been vaccinated once the first 400 cases had occurred, as many as 34,900 (40%) cholera cases and 1,695 deaths (40%) could have been prevented. In the sites with endemic cholera, Kolkata and Zanzibar, a significant number of cases could have been prevented but the impact would have been less dramatic. A brisk response is required for outbreaks with the majority of cases occurring during the early weeks. Even a delayed response can save a substantial number of cases and deaths in long, drawn-out outbreaks. If circumstances prevent a rapid response there are good reasons to roll out cholera mass vaccination campaigns well into the outbreak. Once a substantial proportion of a population is vaccinated, outbreaks in subsequent years may be reduced if not prevented. A single dose vaccine would be of advantage in short, small outbreaks.

Conclusions:
We show that reactive vaccine use can prevent cholera cases and is a rational response to cholera outbreaks in endemic and non-endemic settings. In large and long outbreaks a reactive vaccination with a two-dose vaccine can prevent a substantial proportion of cases. To make mass vaccination campaigns successful, it would be essential to agree when to implement reactive vaccination campaigns and to have a dynamic and determined response team that is familiar with the logistic challenges on standby. Most importantly, the decision makers in donor and recipient countries have to be convinced of the benefit of reactive cholera vaccinations.
DOI http://dx.doi.org/10.1371/journal.pntd.0000952   (check subscription with CDU E-Gateway service for CDU Staff and Students  check subscription with CDU E-Gateway in new window)


© copyright

Every reasonable effort has been made to ensure that permission has been obtained for items included in CDU eSpace. If you believe that your rights have been infringed by this repository, please contact digitisation@cdu.edu.au.

 
Versions
Version Filter Type
Access Statistics: 33 Abstract Views, 38 File Downloads  -  Detailed Statistics
Created: Wed, 03 Jul 2013, 11:22:12 CST by Iwona Rohoza